<PubmedArticle>
<MedlineCitation IndexingMethod="Curated" Owner="NLM" Status="MEDLINE">
<PMID Version="1">27247055</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>09</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-0887</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>120</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>07</Month>
</PubDate>
</JournalIssue>
<Title>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</Title>
<ISOAbbreviation>Radiother Oncol</ISOAbbreviation>
</Journal>
<ArticleTitle>Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial.</ArticleTitle>
<Pagination>
<MedlinePgn>107-13</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.radonc.2016.04.017</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0167-8140(16)31057-X</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE">To investigate which factors are related to patient reported cosmetic outcome (PRCO) after breast conserving therapy.</AbstractText>
<AbstractText Label="METHODS">From 2004 to 2011, 2421 cT1-2N0-2a breast cancer patients were randomised in the Young Boost Trial between a 16 and a 26Gy boost to the tumour bed. Cosmesis was scored subjectively by the patient and physician, and objectively using BCCT.core, at baseline, one and four years after treatment. Presence of fibrosis, QoL and rib pain at four years were also scored. Data were complete for 864 patients. The relation between the separate components was investigated using a proportional odds model.</AbstractText>
<AbstractText Label="RESULTS">Of the 7 BCCT.core parameters, the distance from nipple to inframammary fold and the length of the breast contour were significantly related to the overall PRCO at four years. Patients with more fibrosis and poorer QoL scored their cosmesis worse, while rib pain was not related. The agreement between the different scores was low (kappa 0.26-0.42).</AbstractText>
<AbstractText Label="CONCLUSION">The distance from nipple to inframammary fold, the length of the breast contour and the severity of fibrosis were the main factors related to patient-reported cosmetic outcome. Patients with better QoL scored their cosmesis better.</AbstractText>
<CopyrightInformation>Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Brouwers</LastName>
<ForeName>Patricia J A M</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Maastricht University Medical Center, GROW (MAASTRO), The Netherlands. Electronic address: patricia.brouwers@maastro.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Werkhoven</LastName>
<ForeName>Erik</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bartelink</LastName>
<ForeName>Harry</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fourquet</LastName>
<ForeName>Alain</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Institut Curie, UCBG, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lemanski</LastName>
<ForeName>Claire</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Institut Régional du Cancer Val d'Aurelle, UCBG, Montpellier, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Loon</LastName>
<ForeName>Judith</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Maastricht University Medical Center, GROW (MAASTRO), The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maduro</LastName>
<ForeName>John H</ForeName>
<Initials>JH</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Russell</LastName>
<ForeName>Nicola S</ForeName>
<Initials>NS</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Scheijmans</LastName>
<ForeName>Luc J E E</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schinagl</LastName>
<ForeName>Dominic A X</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>The Netherlands Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Westenberg</LastName>
<ForeName>Antonia H</ForeName>
<Initials>AH</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Radiotherapiegroep, Arnhem, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poortmans</LastName>
<ForeName>Philip</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boersma</LastName>
<ForeName>Liesbeth J</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Maastricht University Medical Center, GROW (MAASTRO), The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>Young Boost Trial research group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>05</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Ireland</Country>
<MedlineTA>Radiother Oncol</MedlineTA>
<NlmUniqueID>8407192</NlmUniqueID>
<ISSNLinking>0167-8140</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001940">Breast</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004954">Esthetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015412">Mastectomy, Segmental</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000071066">Patient Reported Outcome Measures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Breast conserving therapy</Keyword>
<Keyword MajorTopicYN="Y">Cosmetic outcome</Keyword>
<Keyword MajorTopicYN="Y">Patient reported outcome</Keyword>
<Keyword MajorTopicYN="Y">Young boost trial</Keyword>
<Keyword MajorTopicYN="Y">Young patients</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>01</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2016</Year>
<Month>04</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>04</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>6</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>6</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27247055</ArticleId>
<ArticleId IdType="pii">S0167-8140(16)31057-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.radonc.2016.04.017</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>